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Remarkable advances in surgical and catheter management
of congenital heart disease (CHD) over the last half century
have allowed greater than 85% of children with CHD to
survive to adulthood (1). It is estimated that there are now
over 1 million adult survivors with CHD in North America
alone; thus, there are now more adults than children with
CHD in the United States, and the number appears to be
growing by about 5% per year (2). Adults with CHD have
special health care needs and often present complex com-
binations of problems that are generally unrecognized by
those in a traditional internal medicine–based cardiology
training program (3). Medical cardiologists are experts in
the care of adult-acquired diseases that affect the heart and
circulation, but currently most have little or no training in
CHD, particularly in complex disorders. Adult CHD and
clinical experiences for cardiology fellows vary widely (4).
Many adults with CHD continue to be cared for by
pediatric cardiologists because the numbers of medical
cardiologists specializing in this complicated field are few
and insufficient (5,6). This report suggests an approach to
more systematic training of medical cardiologists in the
recognition and care of adults with CHD based upon
previous Bethesda Conference descriptions of workforce
needs and educational requirements (6).
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Levels of Training
We differentiate 3 levels of training and expected expertise
in the care of adult patients with CHD:
Level 1 training represents the level of knowledge
appropriate for all trainees in medical cardiology and indi-
cates the knowledge content that each graduate of such a
program should acquire (6). This level of training should
allow for sufficient knowledge to manage simple adult CHD
and to recognize the moderate or complex diseases and
obtain the appropriate consultations or referrals for proper
care. This level of knowledge should be tested in the
Subspecialty Certification Examination in Cardiovascular
Diseases and will provide the graduate with sufficient
expertise to recognize and evaluate common congenital
heart disorders in adults. This expertise should include
knowledge of the outcomes, residua, sequelae, and compli-
cations of medical management, of invasive catheter-based
therapy, and of surgical palliation, correction, or repair.
Specific disease categories of commonly treated disorders
should be emphasized (see Post-operative residua/sequelae,
Table 1). However, for trainees with Level 1 expertise,
consultation with a pediatric cardiologist or Level 2- or
Level 3-trained adult CHD cardiologist is advisable when
major management decisions are made concerning patients
with moderately to severely complex cardiac disease.
Level 2 training represents additional training for fellows
who plan to care for adult patients with CHD so that they
may acquire expertise in the clinical evaluation and man-
agement of such patients. Some exposure to pediatric
cardiology is recommended. Level 2 training generally
requires 1 year of training in adult CHD: either a 1-year
formal program at a regional or tertiary care adult CHD
center or cumulative experience of 12 months through
repetitive rotations or electives as a cardiology fellow with
experienced adult CHD cardiologists (6). Some consider-
ation can be given to those months spent learning CHD in
general, be it in pediatric, adolescent, or adult CHD
programs. This training should prepare the individual to be
well-equipped for the routine care of even moderate to
complex adult CHD and to recognize when more advanced
consultation or referral is advisable.
Level 3 training represents the level of knowledge
needed by those graduates who wish to make a clinical and
academic/research commitment to this field and not only
become competent in the care of the entire spectrum of
adult patients with CHD but also participate in teaching
and research of adult CHD (6). Some exposure to pediatric
cardiology is recommended. Level 3 trainees generally
require 2 years of training. These 24 months may either be
contiguous or cumulative experience, and some recognition
can be given to overall experience in CHD, be it pediatric,
adolescent, or adult (e.g., prior pediatric cardiology training
or rotations). It is probably preferable that at least 12
months of this training be contiguous in order to obtain
both the maximum clinical continuity of care as well as
sufficient time to dedicate to clinical research in the field.
Such Level 3 training would be sufficient to clinically
manage the most complex adult CHD in a regional or
tertiary center, to pursue an academic career, to train others
in the field, or to direct an adult CHD center program.
Level 1: Basic Training for All Medical
Cardiology Fellows
All medical cardiology trainees should be exposed to a core
of information regarding adults with CHD. The goal of
Level 1 training is for all graduates to be able to recognize
and evaluate common, simple congenital heart lesions and
the sequelae of the more commonly repaired congenital
heart defects. These graduates should always consider con-
sultation and collaborative patient management with a Level
2- or 3-trained specialist or pediatric cardiologist when
major management decisions are made for adults with
CHD and for periodic discussions of ongoing care.
We suggest that at least 6 h of formal lectures within the
core curriculum of the training program be devoted to CHD
in adults. Table 1 indicates the content suggested for these
6 h, covering key basic and clinical aspects of these disor-
ders. A proposed curriculum is as follows: Hour 1  basic
embryology, anatomy, pathology, and physiology and
known genetics of common lesions; Hour 2  clinical
diagnosis (history, exam, electrocardiogram, x-ray) and
management of at least 6 common lesions expected to be
encountered in adults, operated or not; Hour 3  specific
issues relevant to cyanotic CHD and Eisenmenger syn-
drome; Hour 4  explanation of methods and outcomes of
at least 6 usual surgical and catheter palliative and reparative
techniques for CHD; Hour 5  common echocardio-
graphic features in operated and unoperated adult CHD;
and Hour 6  various topics which could include manage-
ment during pregnancy, endocarditis prophylaxis, counsel-
ing on genetics and contraception, employment, and exer-
Level 1 Training in Congenital Heart Diseasein Adults
Table 1 Level 1 Training in Congenital Heart Diseasein Adults
Core Curriculum Knowledge Areas
Basic science Basic embryology, anatomy, pathology,
physiology, genetics
Natural history/
management
Clinical recognition and management of
patients with common defects presenting in
adulthood to include genetic counseling,
care of pregnancy, and management during
noncardiac surgery
Post-operative residua/
sequelae
Includes but is not limited to specific diagnoses
such as tetralogy of Fallot, atrial septal
defects, ventricular septal defects,
transposition of the great arteries (e.g., atrial
baffle and arterial switch operations), single
ventricle (e.g., Fontan operation), and
ventricular outflow tract lesions (all levels of
aortic and pulmonic stenosis and
coarctation of the aorta)
Other Indications for and access to local or regional
expert consultation
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cise. Within those 6 h of core curriculum, the trainees
should be taught about the major outpatient management
issues in adult CHD and when to consult or refer for more
specialized advice. Current available modes of supplement-
ing this education include readily available American Col-
lege of Cardiology educational products (adult CHD sec-
tion of the Adult Clinical Cardiology Self-Assessment
Program and the Echocardiography Self-Assessment Pro-
gram) or Web-based sites specific to CHD.
In addition to the didactic material in the core curricu-
lum, trainees ideally should be exposed to adult patients
with CHD on a regular basis. This could be done in the
context of ongoing weekly case conferences usually already
present in the medical cardiology training program. For
example, at least 1 of the patients discussed in case confer-
ences each month could be an adult with CHD. In addition,
trainees are encouraged to become involved in an ongoing
CHD outpatient clinic, to see older children or adolescents
with a pediatric cardiology colleague, or both. If the training
program does not have expertise in CHD or have access to
CHD locally, partnering with an expert regional adult
CHD facility for an elective rotation of 1 to 4 weeks total
may be a valuable supplement.
Trainees should be exposed to the evaluation of CHD
with various diagnostic modalities during usual clinical
rotations (electrocardiography, electrophysiology, transtho-
racic and transesophageal echocardiography, nuclear cardi-
ology, and the cardiac catheterization laboratory [including
invasive transcatheter techniques]). Exposure to other ad-
vanced imaging techniques now commonly utilized in
CHD (e.g., magnetic resonance imaging [MRI] and com-
puted tomography [CT]) is highly desirable. Didactic ma-
terial for these rotations should include materials on diag-
nosis and management of the adult with CHD.
Level 2: Special Expertise in Adults With
Congenital Heart Disease
At least 1 year of concentrated exposure is generally neces-
sary for those trainees who have little or only basic prior
knowledge of CHD and who wish to care independently for
adult CHD patients. Table 2 indicates the knowledge areas
that should be covered during this year’s period.
In addition to didactic materials, the training should
include the following activities and aims:
1. Participation in a regular (preferably one that meets
more than once a week) outpatient clinic organized for
the care of adults with CHD. The Level 2 trainee
should be involved with the care of a minimum of 10
patients per week.
2. Participation in formal rotations in pediatric cardiology
for either a total block of or cumulative equivalent of 1
to 2 months, including exposure to neonates and chil-
dren with CHD via conferences, outpatient clinics,
diagnostic laboratories (e.g., echocardiography, cathe-
terization laboratory, and so on), and inpatient services
including consultations and exposure to children with
post-operative CHD in the intensive care unit. Given
that such fellows will not likely be experienced in the
critical care of pediatric patients, all inpatient participa-
tion should be observed and supervised by experienced
pediatric cardiologists.
3. Acquisition of familiarity with the range of diagnostic
and therapeutic methods, including direct experience in
echocardiography, cardiac catheterization, and advanced
imaging techniques (MRI and CT), and understanding
of the applications of catheter-based techniques both for
electrophysiologic mapping and arrhythmia ablation
and for anatomic-hemodynamic intervention.
4. Participation in the perioperative care of patients with
CHD (preferably in adults), including direct observa-
tion of surgical repair.
5. Engagement in the perioperative care of in-hospital
patients with CHD with both cardiac and noncardiac
medical and surgical issues.
Program Requirements
Two basic requirements are indicated for a program to train
effectively at Level 2: 1) the presence of associated formal
programs in pediatric cardiology and cardiovascular surgery
and 2) at least 1 faculty member with a career commitment
to the care of adult patients with CHD (this faculty member
should have achieved by either combined lifelong experience
Level 2 Training in Congenital Heart Diseasein Adults
Table 2 Level 2 Training in Congenital Heart Diseasein Adults
Anatomy, physiology, clinical presentation, and natural history of specific lesions
Diagnostic methods
Physical examination
Electrocardiography
Significance of arrhythmias/electrophysiologic testing
Chest roentgenogram
Echocardiography, both transthoracic and transesophageal
Catheterization/angiography
Radionuclide angiography
Other advanced imaging methods; specifically CMR/CT
Therapeutic methods
Pharmacologic management
Surgical procedures
Catheter interventional procedures
Residua and sequelae of interventions (surgical and catheter)
Introduction to appropriate outpatient management
Reproduction issues
Counseling for pregnancy and management during pregnancy and delivery
Contraception
Evaluation for noncardiac surgery
Palliative care (e.g., management of pulmonary vascular obstructive disease)
Athletic and other activity counseling
Employment counseling and socioeconomic issues
Insurability
Psychosocial issues
CT  computed tomography; CMR  cardiovascular magnetic resonance.
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of, or have been specifically trained in, the skills equivalent
to Level 3 training).
Level 3: Advanced Expertise in Adults With
Congenital Heart Disease
To obtain a comprehensive understanding of all aspects of
CHD, a 2-year program is recommended with continued
participation in clinical practice relating to CHD. In addi-
tion to the aforementioned guidelines for Level 2 training,
this training should include active participation in clinical
and/or laboratory research in conjunction with clinical
activities and direct participation in at least 40 diagnostic
cardiac catheterization procedures in CHD, with trainees
demonstrating a comprehensive understanding of the entire
hemodynamic spectrum of anatomic abnormalities in
CHD. Finally, trainees should interpret at least 300 trans-
thoracic echocardiograms and 50 transesophageal echocar-
diographic examinations and have the ability to indepen-
dently interpret such studies in a wide range of CHD (Table
3). The advanced trainee should also be trained in the
interpretation of advanced imaging techniques (i.e., MRI
and/or CT and angiography in CHD.
Because relatively few centers in the United States have
amassed a sufficient number of adult CHD patients who
have been followed up in an organized manner, regional-
ization of training in the care of the complex CHD patient
is necessary (6).
Trainee Evaluation and Documentation of
Core Competence
For Level 1 training in CHD, the global Cardiology
Fellowship Program Director shall: 1) either directly, or via
an adult CHD faculty designee, attest to the clinical
competence of each cardiology fellow; 2) administer a core
competence written and/or oral exam at the finish or
completion of the core 6 adult CHD lectures; 3) require
patient care log documentation of at least 50 supervised
inpatient or outpatient encounters with patients with a
primary diagnosis of some form of CHD during the core
3-year fellowship; and 4) log interpretation of at least 50
supervised adult CHD advanced cardiac diagnostic studies
(cardiac catheterization, echocardiography, and/or cardiac
MRI/CT procedures) during the core 3-year fellowship.
This is a revision of the 2002 document that was originally
written by Carole A. Warnes, MD, MRCP, FACC—Chair;
Michael D. Freed, MD, FACC; Richard R. Liberthson, MD;
and Constantine Mavroudis, MD, FACC.
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Summary of Training Requirements for Care of Adult Patients With Congenital Heart Disease
Table 3 Summary of Training Requirements for Care of Adult Patients With Congenital Heart Disease
Task
Force Area Level
Minimal Number
of Procedures
Cumulative Duration
of Training (Months)
Minimal Cumulative
Number of Cases Comments
9 Congenital heart
disease
1 Core lectures Can be taken as part of
9 months of required
nonlaboratory clinical
practice rotation.
2 12
3 24 40 catheterizations
300 TTE cases
50 TEE cases
TEE  transesophageal echocardiography; TTE  transthoracic echocardiography.
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The missions of the American College of Cardiology and
the American Heart Association have been to ensure
optimal care to those with or at risk for developing cardio-
vascular disease (CVD). The cardiovascular specialist is
expected to contribute significantly to the treatment and
prevention of CVD in the setting of a rapidly growing field
of knowledge ranging from molecular and cellular mecha-
nisms to clinical outcomes. Over the past 2 decades, there
have been dramatic increases in knowledge concerning
specific risk factors in atherosclerosis, hypertension, throm-
bosis, and other forms of vascular dysfunction. Clinical trials
have proven that strategies aimed at the appropriate detec-
tion and modification of risk factors can slow progression of
atherosclerosis and hypertension and reduce the occurrence
of clinical events in both primary and secondary prevention
settings. More recently, it has been shown that atheroscle-
rosis can be stabilized or even modestly reversed. Finally, the
growing knowledge base of molecular genetics applied to
the study of the cardiovascular system has a potentially great
relevance to the future clinical practice of preventive cardio-
vascular medicine.
Despite the fact that clinical outcomes can be improved
by promotion of favorable life habits and behaviors and by
the proper use of drug treatment, the application of preven-
tive interventions in the clinical practice of cardiovascular
medicine is not optimal. Prevention of CVD, in both the
primary and secondary prevention setting, must no longer
be peripheral to the practice of the cardiovascular specialist.
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